Patents | Intellepedia

FMC Corporation’s Plea to Block Natco’s Cyantraniliprole Insecticide Formulation Denied

Chemical formula backdrop with text Natco wins dispute over Cyantraniliprole intermediate patent

Delhi High Court refused FMC’s interim plea on a Cyantraniliprole intermediate, citing credible invalidity under Sections 64(1)(a) and 64(1)(e) and a tenable Gillette defence. With expiry close, damages suffice rather than an injunction.

Court Clarifies Rules on Confidentiality Clubs and Comparable Licenses in SEP Patent Disputes: Nokia v. Asustek & Ors (2025)

Cartoon banner showing a blond boy holding a finger to his lips in a “shhh” gesture, beside a speech bubble that reads “Shhhhhh..!! It’s Confidential…” on a purple-to-yellow gradient background.

Delhi Hight Court clarifies SEP rules on Confidentiality Clubs and license redactions in Nokia v. Asustek, allowing in-house access without restrictions.

Court Allows EMD Millipore’s IR Spectroscopy Patent, Clarifies Scope of Sections 3(i) and 59

Blue DNA banner for article on EMD Millipore v. Controller of Patents interpreting Section 3(i) of the Patents Act.

Delhi HC green-lights EMD Millipore’s IR spectroscopy patent and narrows the sweep of Section 3(i), while affirming compliant claim amendments under Section 59.

Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement Case

Prescription medicine bottles and tablets placed on a courtroom bench, symbolizing a pharmaceutical patent dispute and legal ruling.

In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.

Patent Refusal Cannot Be a Single Line: Calcutta High Court Calls for Reasoned Orders

Yellow road marking with bold black text reading “SINGLE LINE. DO NOT CROSS,” symbolizing the lack of reasoning in the Stromag GmbH patent refusal—a single-line decision that violated principles of natural justice.

In the case of Stromag GmbH vs. Controller General of Patents, the Calcutta High Court ruled that patent refusal orders must contain detailed reasoning. A single-line dismissal, the court said, does not meet the legal standards of a quasi-judicial function and is unsustainable.

Infrared-Based Biomolecule Detection is Not excluded under Section 3(i) of the Patents Act: Delhi HC

Close-up of a metallic microscope lens projecting an infrared beam onto stylized chemical structures, with DNA-like strands and an “IR” graph on a dark background.

In the case of EMD Millipore Corporation vs Assistant Controller of Patents and Designs, the Delhi High Court held that a non-invasive method for analysing biomolecules is not excluded from patentability under Section 3(i). The Court allowed the applicant to revert to earlier claims and upheld the right to amend claims in appeal.

Section 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing Method

DNA gel bands with a magnifying glass highlighting DNA bases and the word “Disease

Delhi HC rules Sequenom’s NIPT methods are excluded as “diagnostic” under Section 3(i) and hit by 3(b) for sex selection concerns, while keeping the door open for tools and products.

Roche’s Appeal Dismissed, Path Open for Affordable Risdiplam in India

Illustration of a medicine bottle labeled “Risdiplam” next to the word “unaffordable,” with a hand using scissors to cut off the “un” prefix, symbolizing making the drug affordable.

The Delhi High Court dismissed Roche’s appeal against Natco Pharma, finding the Risdiplam patent prima facie obvious due to its similarity with prior genus patents, paving the way for affordable generic SMA treatment in India.

Calcutta High Court Clarifies Scope of Section 3(h) in Patent Law: Base SE v. Controller of Patents

Silhouette of a farmer spraying crops with pesticides on one side and a tractor on the other, with rows of crop plants in between, set against a green background.

In Base SE v. Deputy Controller of Patents, the Calcutta High Court ruled that scientific and technical inventions addressing agricultural problems are not excluded under Section 3(h). It also clarified that partial grant of patent claims is not permitted under Indian patent law.

Saint-Gobain Patent Rejection: Delhi HC Finds No Inventive Step in Glass Coating Claim

Illustration of a judge holding a gavel beside broken glass shards, with the text "Delhi High Court Rejects Saint-Gobain's Patent Application on Glass Coatings Due to Lack of Inventive Step" on a pastel gradient background.

Delhi HC upholds Saint-Gobain patent rejection, ruling that the glass coating claim lacked inventive step and failed to show technical advancement.